One of the hypotheses underlying the mechanisms involved in NKp30 down regulation in AML, a chronic exposure to Nkp30 ligands such as B7-H6 or BAG6 has been proposed and demonstrated in other cancers [59]. Here, BAG6 is linked to acute myeloid leukemia.